Comparison Between Velys J&J Robotic-assisted and Cori S&N Robotic-assisted Total Knee Arthroplasty (TKA)

April 21, 2026 updated by: Jakub Błaszczyk, Jan Biziel University Hospital No 2 in Bydgoszcz
This randomised controlled trial will include patients with end-stage osteoarthritis of the knee undergoing primary TKR. Patients meeting the criteria that consent to be in the study will be randomised at a ratio of 1:1 to either Velys J&J robotic-assisted or Cori S&N robotic-assisted TKR. The primary objective will assess pre- and postoperative HKA angle, CPAK and range of motion using goniometer to compare two groups.The secondary objectives are to compare patient expectation, functional ability, quality of life using functional 48-point Oxford Knee Score and Forgotten joint score.

Study Overview

Detailed Description

This randomised controlled trial will include patients with end-stage osteoarthritis of the knee undergoing primary TKR. Patients meeting the criteria that consent to be in the study will be randomised at a ratio of 1:1 to either Velys J&J robotic-assisted or Cori S&N robotic-assisted TKR. The primary objective will assess pre- and postoperative HKA angle, CPAK and range of motion using goniometer to compare two groups.The secondary objectives are to compare patient expectation, functional ability, quality of life using functional 48-point Oxford Knee Score and Forgotten joint score.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kuyavian-Pomeranian Voivodeship
      • Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland, 85-168
        • Dr. Jan Biziel University Hospital No. 2 in Bydgoszcz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

patients with end-stage osteoarthritis of the knee undergoing primary TKR.

Description

Inclusion Criteria:

gonarthrosis

Exclusion Criteria:

heavy systemic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Velys J&J robotic assisted TKA
We prepare TKA using Velys J&J robotic arm
assess preoperative HKA
assess preoperative Oxford Knee Score
assess preoperative Forgotten Joint Score
assess preoperative range-of-motion
postoperative HKA
postoperative CPAK
postoperative range-of-motion
postoperative Oxford Knee Score
postoperative Forgotten Joint Score
asses preoperative CPAK
Cori S&N robotic assisted TKA
We prepare TKA using Cori S&N robotic arm
assess preoperative HKA
assess preoperative Oxford Knee Score
assess preoperative Forgotten Joint Score
assess preoperative range-of-motion
postoperative HKA
postoperative CPAK
postoperative range-of-motion
postoperative Oxford Knee Score
postoperative Forgotten Joint Score
asses preoperative CPAK

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
1. HKA angle
Time Frame: before and 3,6,12 after surgery
before and 3,6,12 after surgery
CPAK
Time Frame: before and 3,6,12 months after surgery
before and 3,6,12 months after surgery
range-of-motion
Time Frame: before and 3,6,12 moths after surgery
before and 3,6,12 moths after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Oxford Knee Score
Time Frame: before and 3,6,12 months after surgery
before and 3,6,12 months after surgery
Forgotten Joint Score
Time Frame: before and 3,6,12 moths after surgery
before and 3,6,12 moths after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jakub Błaszczyk, Dr. Jan Biziel University Hospital No. 2 in Bydgoszcz
  • Principal Investigator: Michał Kułakowski, PhD, Dr. Jan Biziel University Hospital No. 2 in Bydgoszcz
  • Principal Investigator: Karol Elster, PhD, Dr. Jan Biziel University Hospital No. 2 in Bydgoszcz
  • Principal Investigator: Jiří PhD Skála-Rosenbaum, University Hospital Královské Vinohrady
  • Principal Investigator: Jakub Maléř, University Hospital Královské Vinohrady

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2026

Primary Completion (Actual)

January 10, 2026

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

April 21, 2026

First Submitted That Met QC Criteria

April 21, 2026

First Posted (Actual)

April 28, 2026

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KEL 12/2026

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthritis Osteoarthritis

Clinical Trials on preoperative HKA

Subscribe